In this review, we provide a comprehensive overview of the pathogenic role of CXCL13/CXCR5 axis in autoimmune diseases, while also discussing the potential usage of CXCL13 as a novel clinical biomarker and treatment target. The gene discussed is CXCL13; the disease is autoimmune disease.